Publication details

Patient with inoperable pheochromocytoma

Authors

BRANČÍKOVÁ Dagmar MECHL Zdeněk ADAM Zdeněk JANDÁKOVÁ Eva PAVLOVSKÝ Zdeněk VÁLEK Vlastimil ANDRAŠINA Tomáš

Year of publication 2015
Type Article in Periodical
Magazine / Source Current Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Doi http://dx.doi.org/10.3747/co.22.2324
Field Oncology and hematology
Keywords Pheochromocytoma; chemoembolization; lanreotide
Description Malignant pheochromocytoma is a tumour with a very low incidence that occurs sporadically or in the presence of multiple endocrine neoplasia. We present the case of a woman with a sporadic occurrence of pheochromocytoma diagnosed in the phase of multiple dissemination in the abdominal cavity and overexpressing adrenaline, noradrenaline, and dopamine. Local transarterial chemoembolization and systemic treatment with lanreotide resulted in a very good response, a decrease in the production of catecholamines for 12 months and a partial decrease for another 8 months, with stabilization of disease determined by imaging. Systemic treatment with tegafur resulted in disease stabilization lasting 50 months, after which the drug was discontinued because of adverse effects. Maintenance therapy with lanreotide continues, and no disease progression has been observed for 4 months. The treatment algorithm for such patients is multidisciplinary and must always take into account the current scope of the disease, intercurrence, and the general condition of the patient.

You are running an old browser version. We recommend updating your browser to its latest version.

More info